These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 31733575)

  • 1. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
    Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
    Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
    Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
    J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
    Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
    Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
    Zhou Z; Wu B; Tang X; Ke R; Zou Q
    Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validation.
    Wang N; Zhang H; Li D; Jiang C; Zhao H; Teng Y
    Bioengineered; 2021 Dec; 12(2):12431-12446. PubMed ID: 34895070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
    Ren H; Hu D; Mao Y; Su X
    Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
    Bendrat K; Fritz P; Müller S; Brockmöller S; Debus A; Friedrichs K; Lindner C; Brinkmann F; Heidemann E; Niendorf A
    Anticancer Res; 2016 Aug; 36(8):3855-63. PubMed ID: 27466487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.